TheEdgeResearch
Home / Stocks / AVCRF

Avricore Health Inc. (AVCRF)

OTC Healthcare Medical - Diagnostics & Research
$0.00 ▲ +0.00%
Market Cap
$81,032
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.32
52-Wk Range
0.00079999998-0.07868
CEO
Rodger Seccombe
Country
CA
Currency
USD

Avricore Health Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $81,032. On trailing twelve-month figures it carries a trailing P/E of -3.69, a net margin of -933.8%. Its beta of 0.32 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.69
Price / Sales
34.11
Price / Book
6.14
EV / EBITDA
-4.62
Gross margin
-36.8%
Operating margin
-677.3%
Net margin
-933.8%
Return on equity
—
Debt / equity
0.00
Current ratio
8.24
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
26
IPO date
2009-06-19
Headquarters
Vancouver, BC, CA
About Avricore Health Inc.

Avricore Health Inc. is a Canadian company specializing in health data and immediate diagnostic technologies. Its core offering is HealthTab, a proprietary platform providing precise, lab-quality point-of-care testing specifically designed for pharmacy environments. The company boasts significant strategic alliances, notably with Shoppers Drug Marts and Abbott. Founded in 1996, the Vancouver, Canada-based enterprise previously operated as Vanc Pharmaceuticals Inc. before officially adopting the name Avricore Health Inc. in October 2018.

Comparable companies

Avricore Health Inc. is most often compared with the following Healthcare names:

AVTBFBBRRFBUDZICBUIDXGPMEDFRNVATDSGFTHCBFVDQSF
More research on AVCRF
AVCRF technical analysis AVCRF TheEdge Score Compare against peers
Open full interactive analysis & DCF →